Phio Pharmaceuticals Corp (PHIO)

[Nothole]

YES I HAVE LOST BIG BUT EACH TIME AND ESPECIALLY NOW I HAVE/AM TAKING ADVANTAGE OF THE VERY LOW PPS. I especially like the price of PHIOW. PHIO PARTNERS: GUSTAVE ROUSEY, CCIT, MEDIGENE, IOVANCE, KAROLINSKA and Glycostem are all well respected and credible institutions. These cancer investigators would not have engaged with Phio Pharma unless they were convinced with the Phio Technology.

Yes it has been very painful and financially disappointing. However, I have not seen anything discouraging with regards to the RNAi Technology.

With regards to the Opthomalogy & Dermatology Technology SALE, the Phio story of starting with 50 Potential Buyers in February 2018 then 12 Potential Buyers by June 2018 and then down to 6 Potential Buyers doing their own Laboratory Due Diligence in August, is typical of such laboratory investigations in order to be completely convinced of the validity of the Opthomalogy and Dermatology Technology in order for those Potential Buyers to justify a serious BID PRICE FOR THE PHIO TECHNOLOGY. Not only do investigators have to see a positive result but then they have to wait several months to see if there is any regression back to the original condition.

Until I loose confidence in the PHIO TECHNOLOGY = I WILL CONTINUE TO CHASE THIS STOCK EVEN AT RISK OF A TOTAL LOSS. THE REWARD RATIO IS CLOSE TO BUYING APPLE @ $10 BACK IN 1980.